Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,798,018
-
Total 13F shares
-
52,358,250
-
Share change
-
+1,420,586
-
Total reported value
-
$9,021,227,777
-
Put/Call ratio
-
68%
-
Price per share
-
$172.43
-
Number of holders
-
365
-
Value change
-
+$258,694,966
-
Number of buys
-
178
-
Number of sells
-
167
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2015
As of 31 Mar 2015,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
365 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,358,250 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, SCOPIA CAPITAL MANAGEMENT LP, BlackRock Fund Advisors, LSV ASSET MANAGEMENT, BlackRock Advisors LLC, ACADIAN ASSET MANAGEMENT LLC, DEUTSCHE BANK AG\, BlackRock Institutional Trust Company, N.A., and IRIDIAN ASSET MANAGEMENT LLC/CT.
This page lists
362
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.